IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $590,100 | +61.7% | 15,000 | 0.0% | 0.14% | +45.8% |
| Q1 2023 | $364,950 | +13.6% | 15,000 | 0.0% | 0.10% | +3.2% |
| Q4 2022 | $321,150 | +19.4% | 15,000 | 0.0% | 0.09% | +22.4% |
| Q3 2022 | $269,000 | +86.8% | 15,000 | 0.0% | 0.08% | +81.0% |
| Q2 2022 | $144,000 | -42.9% | 15,000 | 0.0% | 0.04% | -25.0% |
| Q1 2022 | $252,000 | +0.4% | 15,000 | 0.0% | 0.06% | +9.8% |
| Q4 2021 | $251,000 | +2.9% | 15,000 | 0.0% | 0.05% | -3.8% |
| Q3 2021 | $244,000 | – | 15,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |